In the context of chronic inflammation, sustained activation of NKG2D may lead to tissue damage and tumor progression, and NKG2D-positive NK and T cells may become functionally downregulated or desensitized due to continuous ligand engagement in the tumor microenvironment. Here, KLRK1 is linked to neoplasm.